CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL. NONEXCLUSIVE LICENSE AND DEVELOPMENT AGREEMENTNonexclusive License and Development Agreement • November 8th, 2023 • Gritstone Bio, Inc. • Biological products, (no disgnostic substances) • New York
WHEREAS Genevant has expertise and intellectual property relating to, among other things, LNP (as defined below) formulations for delivery of nucleic acid (such as ribonucleic acid) and methods for manufacturing LNPs;
